These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9603651)

  • 1. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
    Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
    J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
    Oellerich M; Armstrong VW; Schütz E; Shaw LM
    Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
    [No Abstract]   [Full Text] [Related]  

  • 3. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center.
    Okamoto M; Omori Y; Kadotani Y; Ushigome H; Nakamura K; Akioka K; Yoshimura N
    Transplant Proc; 2002 Aug; 34(5):1666. PubMed ID: 12176527
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
    Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of tacrolimus early after liver transplantation.
    Braun F; Peters B; Schütz E; Lorf T; Undre N; Oellerich M; Ringe B
    Transplant Proc; 2002 Aug; 34(5):1538-9. PubMed ID: 12176473
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
    Hu RH; Lee PH; Tsai MK
    Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
    Hedayat S; Kershner RP; Su G
    J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
    van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
    [No Abstract]   [Full Text] [Related]  

  • 12. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
    Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
    Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus therapeutic drug monitoring and pediatric renal transplant graft outcomes.
    Larkins N; Matsell DG
    Pediatr Transplant; 2014 Dec; 18(8):803-9. PubMed ID: 25284168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus in pediatric renal transplantation: a review.
    Shapiro R
    Pediatr Transplant; 1998 Nov; 2(4):270-6. PubMed ID: 10084728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.
    Hougardy JM; Broeders N; Kianda M; Massart A; Madhoun P; Le Moine A; Hoang AD; Mikhalski D; Wissing KM; Abramowicz D
    Transplantation; 2011 Mar; 91(5):566-9. PubMed ID: 21192316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study.
    Webb NJA; Baumann U; Camino M; Frauca E; Undre N;
    Pediatr Transplant; 2019 Feb; 23(1):e13328. PubMed ID: 30665258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation.
    Moreno M; Manzanares C; Castellano F; Medina E; Urruzuno P; Camarena C; Manzanares J; Jara P
    Ther Drug Monit; 1998 Aug; 20(4):376-9. PubMed ID: 9712459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
    Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
    Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.